Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The role of intestinal microbiota in cardiovascular diseaseJournal of cellular and molecular medicine, 2019-04, Vol.23 (4), p.2343-2350 [Peer Reviewed Journal]2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14195 ;PMID: 30712327Full text available |
|
2 |
Material Type: Article
|
High‐mobility group box‐1 induces vascular remodelling processes via c‐Jun activationJournal of cellular and molecular medicine, 2015-05, Vol.19 (5), p.1151-1161 [Peer Reviewed Journal]2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright © 2015 Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine ;2015. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2015 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12519 ;PMID: 25726846Full text available |
|
3 |
Material Type: Article
|
Transcriptomic analysis identifies Toll‐like and Nod‐like pathways and necroptosis in pulmonary arterial hypertensionJournal of cellular and molecular medicine, 2020-10, Vol.24 (19), p.11409-11421 [Peer Reviewed Journal]2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.15745 ;PMID: 32860486Full text available |
|
4 |
Material Type: Article
|
NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertensionJournal of cellular and molecular medicine, 2021-01, Vol.25 (2), p.1221-1237 [Peer Reviewed Journal]2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16193 ;PMID: 33340241Full text available |
|
5 |
Material Type: Article
|
LncRNA PAXIP1‐AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axisJournal of cellular and molecular medicine, 2021-08, Vol.25 (15), p.7321-7334 [Peer Reviewed Journal]2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16761 ;PMID: 34245091Full text available |
|
6 |
Material Type: Article
|
Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in ChinaJournal of cellular and molecular medicine, 2020-02, Vol.24 (4), p.2484-2496 [Peer Reviewed Journal]2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14937 ;PMID: 31945804Full text available |
|
7 |
Material Type: Article
|
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathwayJournal of cellular and molecular medicine, 2023-03, Vol.27 (5), p.622-633 [Peer Reviewed Journal]2023 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.17681 ;PMID: 36762748Full text available |
|
8 |
Material Type: Article
|
Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart diseaseJournal of cellular and molecular medicine, 2018-12, Vol.22 (12), p.6249-6261 [Peer Reviewed Journal]2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13912 ;PMID: 30338626Full text available |
|
9 |
Material Type: Article
|
The protective effects of MSC‐EXO against pulmonary hypertension through regulating Wnt5a/BMP signalling pathwayJournal of cellular and molecular medicine, 2020-12, Vol.24 (23), p.13938-13948 [Peer Reviewed Journal]2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16002 ;PMID: 33090702Full text available |
|
10 |
Material Type: Article
|
Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive ratsJournal of cellular and molecular medicine, 2015-08, Vol.19 (8), p.1965-1974 [Peer Reviewed Journal]2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright © 2015 John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine ;2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2015 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12573 ;PMID: 25766467Full text available |
|
11 |
Material Type: Article
|
The preventive and therapeutic effects of AAV1‐KLF4‐shRNA in cigarette smoke‐induced pulmonary hypertensionJournal of cellular and molecular medicine, 2021-01, Vol.25 (2), p.1238-1251 [Peer Reviewed Journal]2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16194 ;PMID: 33342082Full text available |
|
12 |
Material Type: Article
|
Analysis of necroptosis and its association with pyroptosis in organ damage in experimental pulmonary arterial hypertensionJournal of cellular and molecular medicine, 2022-05, Vol.26 (9), p.2633-2645 [Peer Reviewed Journal]2022 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.17272 ;PMID: 35393789Full text available |
|
13 |
Material Type: Article
|
Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stressJournal of cellular and molecular medicine, 2021-11, Vol.25 (22), p.10389-10402 [Peer Reviewed Journal]2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16968 ;PMID: 34609050Full text available |
|
14 |
Material Type: Article
|
Identification of immune‐associated signatures and potential therapeutic targets for pulmonary arterial hypertensionJournal of cellular and molecular medicine, 2023-12, Vol.27 (23), p.3864-3877 [Peer Reviewed Journal]2023 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.17962 ;PMID: 37753829Full text available |
|
15 |
Material Type: Article
|
Sodium butyrate attenuates angiotensin II‐induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6‐dependent mechanismJournal of cellular and molecular medicine, 2019-12, Vol.23 (12), p.8139-8150 [Peer Reviewed Journal]2019 The Authors. published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14684 ;PMID: 31565858Full text available |
|
16 |
Material Type: Article
|
Construction of a ceRNA coregulatory network and screening of hub biomarkers for salt‐sensitive hypertensionJournal of cellular and molecular medicine, 2020-07, Vol.24 (13), p.7254-7265 [Peer Reviewed Journal]2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.15285 ;PMID: 32410228Full text available |
|
17 |
Material Type: Article
|
Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodentsJournal of cellular and molecular medicine, 2021-11, Vol.25 (21), p.10073-10087 [Peer Reviewed Journal]2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16940 ;PMID: 34647412Full text available |
|
18 |
Material Type: Article
|
NAADP‐induced intracellular calcium ion is mediated by the TPCs (two‐pore channels) in hypoxia‐induced pulmonary arterial hypertensionJournal of cellular and molecular medicine, 2021-08, Vol.25 (15), p.7485-7499 [Peer Reviewed Journal]2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16783 ;PMID: 34263977Full text available |
|
19 |
Material Type: Article
|
Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fractionJournal of cellular and molecular medicine, 2019-10, Vol.23 (10), p.6666-6678 [Peer Reviewed Journal]2019 The Authors. published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14542 ;PMID: 31368189Full text available |
|
20 |
Material Type: Article
|
MiR‐629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERPJournal of cellular and molecular medicine, 2019-08, Vol.23 (8), p.5165-5175 [Peer Reviewed Journal]2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14385 ;PMID: 31240850Full text available |